Cargando…

Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum

BACKGROUND: 9α-hydroxyandrost-4-ene-3,17-dione (9-OHAD) is a significant intermediate for the synthesis of glucocorticoid drugs. However, in the process of phytosterol biotransformation to manufacture 9-OHAD, product degradation, and by-products restrict 9-OHAD output. In this study, to construct a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiangcen, Zhang, Jingxian, Yuan, Chenyang, Du, Guilin, Han, Suwan, Shi, Jiping, Sun, Junsong, Zhang, Baoguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018825/
https://www.ncbi.nlm.nih.gov/pubmed/36922830
http://dx.doi.org/10.1186/s12934-023-02052-y
_version_ 1784907891769081856
author Liu, Xiangcen
Zhang, Jingxian
Yuan, Chenyang
Du, Guilin
Han, Suwan
Shi, Jiping
Sun, Junsong
Zhang, Baoguo
author_facet Liu, Xiangcen
Zhang, Jingxian
Yuan, Chenyang
Du, Guilin
Han, Suwan
Shi, Jiping
Sun, Junsong
Zhang, Baoguo
author_sort Liu, Xiangcen
collection PubMed
description BACKGROUND: 9α-hydroxyandrost-4-ene-3,17-dione (9-OHAD) is a significant intermediate for the synthesis of glucocorticoid drugs. However, in the process of phytosterol biotransformation to manufacture 9-OHAD, product degradation, and by-products restrict 9-OHAD output. In this study, to construct a stable and high-yield 9-OHAD producer, we investigated a combined strategy of blocking Δ(1)‑dehydrogenation and regulating metabolic flux. RESULTS: Five 3-Ketosteroid-Δ(1)-dehydrogenases (KstD) were identified in Mycobacterium fortuitum ATCC 35855. KstD2 showed the highest catalytic activity on 3-ketosteroids, followed by KstD3, KstD1, KstD4, and KstD5, respectively. In particular, KstD2 had a much higher catalytic activity for C9 hydroxylated steroids than for C9 non-hydroxylated steroids, whereas KstD3 showed the opposite characteristics. The deletion of kstDs indicated that KstD2 and KstD3 were the main causes of 9-OHAD degradation. Compared with the wild type M. fortuitum ATCC 35855, MFΔkstD, the five kstDs deficient strain, realized stable accumulation of 9-OHAD, and its yield increased by 42.57%. The knockout of opccr or the overexpression of hsd4A alone could not reduce the metabolic flux of the C22 pathway, while the overexpression of hsd4A based on the knockout of opccr in MFΔkstD could remarkably reduce the contents of 9,21 ‑dihydroxy‑20‑methyl‑pregna‑4‑en‑3‑one (9-OHHP) by-products. The inactivation of FadE28-29 leads to a large accumulation of incomplete side-chain degradation products. Therefore, hsd4A and fadE28-29 were co-expressed in MFΔkstDΔopccr successfully eliminating the two by-products. Compared with MFΔkstD, the purity of 9-OHAD improved from 80.24 to 90.14%. Ultimately, 9‑OHAD production reached 12.21 g/L (83.74% molar yield) and the productivity of 9-OHAD was 0.0927 g/L/h from 20 g/L phytosterol. CONCLUSIONS: KstD2 and KstD3 are the main dehydrogenases that lead to 9-OHAD degradation. Hsd4A and Opccr are key enzymes regulating the metabolic flux of the C19- and C22-pathways. Overexpression of fadE28-29 can reduce the accumulation of incomplete degradation products of the side chains. According to the above findings, the MF-FA5020 transformant was successfully constructed to rapidly and stably accumulate 9-OHAD from phytosterols. These results contribute to the understanding of the diversity and complexity of steroid catabolism regulation in actinobacteria and provide a theoretical basis for further optimizing industrial microbial catalysts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-023-02052-y.
format Online
Article
Text
id pubmed-10018825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100188252023-03-17 Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum Liu, Xiangcen Zhang, Jingxian Yuan, Chenyang Du, Guilin Han, Suwan Shi, Jiping Sun, Junsong Zhang, Baoguo Microb Cell Fact Research BACKGROUND: 9α-hydroxyandrost-4-ene-3,17-dione (9-OHAD) is a significant intermediate for the synthesis of glucocorticoid drugs. However, in the process of phytosterol biotransformation to manufacture 9-OHAD, product degradation, and by-products restrict 9-OHAD output. In this study, to construct a stable and high-yield 9-OHAD producer, we investigated a combined strategy of blocking Δ(1)‑dehydrogenation and regulating metabolic flux. RESULTS: Five 3-Ketosteroid-Δ(1)-dehydrogenases (KstD) were identified in Mycobacterium fortuitum ATCC 35855. KstD2 showed the highest catalytic activity on 3-ketosteroids, followed by KstD3, KstD1, KstD4, and KstD5, respectively. In particular, KstD2 had a much higher catalytic activity for C9 hydroxylated steroids than for C9 non-hydroxylated steroids, whereas KstD3 showed the opposite characteristics. The deletion of kstDs indicated that KstD2 and KstD3 were the main causes of 9-OHAD degradation. Compared with the wild type M. fortuitum ATCC 35855, MFΔkstD, the five kstDs deficient strain, realized stable accumulation of 9-OHAD, and its yield increased by 42.57%. The knockout of opccr or the overexpression of hsd4A alone could not reduce the metabolic flux of the C22 pathway, while the overexpression of hsd4A based on the knockout of opccr in MFΔkstD could remarkably reduce the contents of 9,21 ‑dihydroxy‑20‑methyl‑pregna‑4‑en‑3‑one (9-OHHP) by-products. The inactivation of FadE28-29 leads to a large accumulation of incomplete side-chain degradation products. Therefore, hsd4A and fadE28-29 were co-expressed in MFΔkstDΔopccr successfully eliminating the two by-products. Compared with MFΔkstD, the purity of 9-OHAD improved from 80.24 to 90.14%. Ultimately, 9‑OHAD production reached 12.21 g/L (83.74% molar yield) and the productivity of 9-OHAD was 0.0927 g/L/h from 20 g/L phytosterol. CONCLUSIONS: KstD2 and KstD3 are the main dehydrogenases that lead to 9-OHAD degradation. Hsd4A and Opccr are key enzymes regulating the metabolic flux of the C19- and C22-pathways. Overexpression of fadE28-29 can reduce the accumulation of incomplete degradation products of the side chains. According to the above findings, the MF-FA5020 transformant was successfully constructed to rapidly and stably accumulate 9-OHAD from phytosterols. These results contribute to the understanding of the diversity and complexity of steroid catabolism regulation in actinobacteria and provide a theoretical basis for further optimizing industrial microbial catalysts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-023-02052-y. BioMed Central 2023-03-16 /pmc/articles/PMC10018825/ /pubmed/36922830 http://dx.doi.org/10.1186/s12934-023-02052-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Xiangcen
Zhang, Jingxian
Yuan, Chenyang
Du, Guilin
Han, Suwan
Shi, Jiping
Sun, Junsong
Zhang, Baoguo
Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title_full Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title_fullStr Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title_full_unstemmed Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title_short Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ(1)-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum
title_sort improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-δ(1)-dehydrogenase deletions and multiple genetic modifications in mycobacterium fortuitum
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018825/
https://www.ncbi.nlm.nih.gov/pubmed/36922830
http://dx.doi.org/10.1186/s12934-023-02052-y
work_keys_str_mv AT liuxiangcen improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT zhangjingxian improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT yuanchenyang improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT duguilin improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT hansuwan improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT shijiping improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT sunjunsong improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum
AT zhangbaoguo improvingtheproductionof9ahydroxy4androstene317dionefromphytosterolsby3ketosteroidd1dehydrogenasedeletionsandmultiplegeneticmodificationsinmycobacteriumfortuitum